BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 12555246)

  • 1. Effects of retinoic acid on proliferation, apoptosis, cytotoxicity, migration, and invasion of neuroblastoma cells.
    Voigt A; Zintl F
    Med Pediatr Oncol; 2003 Apr; 40(4):205-13. PubMed ID: 12555246
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal cell differentiation of human neuroblastoma cells by retinoic acid plus herbimycin A.
    Preis PN; Saya H; Nádasdi L; Hochhaus G; Levin V; Sadée W
    Cancer Res; 1988 Nov; 48(22):6530-4. PubMed ID: 2846152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Participation of type II protein kinase A in the retinoic acid-induced growth inhibition of SH-SY5Y human neuroblastoma cells.
    Kim SN; Kim SG; Park SD; Cho-Chung YS; Hong SH
    J Cell Physiol; 2000 Mar; 182(3):421-8. PubMed ID: 10653609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of integrin alpha2beta1 on invasion and migration of neuroblastoma cells].
    Zou CY; Wen FQ; Chen YX; Liu ZP; Zhang ZX
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Jun; 10(3):386-90. PubMed ID: 18554474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential sensitivity of chemoresistant neuroblastoma subtypes to MAPK-targeted treatment correlates with ERK, p53 expression, and signaling response to U0126.
    Eppstein AC; Sandoval JA; Klein PJ; Woodruff HA; Grosfeld JL; Hickey RJ; Malkas LH; Schmidt CM
    J Pediatr Surg; 2006 Jan; 41(1):252-9. PubMed ID: 16410143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of N-(4-hydroxyphenyl)retinamide and retinoic acid on neuroblastoma cells: apoptosis versus differentiation.
    Ponzoni M; Bocca P; Chiesa V; Decensi A; Pistoia V; Raffaghello L; Rozzo C; Montaldo PG
    Cancer Res; 1995 Feb; 55(4):853-61. PubMed ID: 7850799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Bcl-2 oncoprotein levels with differentiation of human neuroblastoma cells.
    Hanada M; Krajewski S; Tanaka S; Cazals-Hatem D; Spengler BA; Ross RA; Biedler JL; Reed JC
    Cancer Res; 1993 Oct; 53(20):4978-86. PubMed ID: 8402688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
    Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
    J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of LOX/COX inhibitors on cell differentiation induced by all-trans retinoic acid in neuroblastoma cell lines.
    Redova M; Chlapek P; Loja T; Zitterbart K; Hermanova M; Sterba J; Veselska R
    Int J Mol Med; 2010 Feb; 25(2):271-80. PubMed ID: 20043138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retinoic acid receptors and tissue-transglutaminase mediate short-term effect of retinoic acid on migration and invasion of neuroblastoma SH-SY5Y cells.
    Joshi S; Guleria R; Pan J; DiPette D; Singh US
    Oncogene; 2006 Jan; 25(2):240-7. PubMed ID: 16158052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential expression of nuclear matrix proteins during the differentiation of human neuroblastoma SK-N-SH cells induced by retinoic acid.
    Liang Y; Li QF; Zhang XY; Shi SL; Jing GJ
    J Cell Biochem; 2009 Apr; 106(5):849-57. PubMed ID: 19160409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of ellagic acid on proliferation, cell adhesion and apoptosis in SH-SY5Y human neuroblastoma cells.
    Fjaeraa C; Nånberg E
    Biomed Pharmacother; 2009 May; 63(4):254-61. PubMed ID: 18848760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation of neuroblastoma enhances Bcl-2 expression and induces alterations of apoptosis and drug resistance.
    Lasorella A; Iavarone A; Israel MA
    Cancer Res; 1995 Oct; 55(20):4711-6. PubMed ID: 7553653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytotoxicity of alpha-particle-emitting m-[211At]astatobenzylguanidine on human neuroblastoma cells.
    Strickland DK; Vaidyanathan G; Zalutsky MR
    Cancer Res; 1994 Oct; 54(20):5414-9. PubMed ID: 7923174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of all-trans-retinoic acid on human SH-SY5Y neuroblastoma as in vitro model in neurotoxicity research.
    Cheung YT; Lau WK; Yu MS; Lai CS; Yeung SC; So KF; Chang RC
    Neurotoxicology; 2009 Jan; 30(1):127-35. PubMed ID: 19056420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinct mechanisms of cell cycle arrest control the decision between differentiation and senescence in human neuroblastoma cells.
    Wainwright LJ; Lasorella A; Iavarone A
    Proc Natl Acad Sci U S A; 2001 Jul; 98(16):9396-400. PubMed ID: 11481496
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential drug sensitivity of human neuroblastoma cells.
    Spengler BA; Ross RA; Biedler JL
    Cancer Treat Rep; 1986 Aug; 70(8):959-65. PubMed ID: 3731152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI; Pettersen I; Ponthan F; Sveinbjørnsson B; Flaegstad T; Kogner P
    Int J Oncol; 2004 Dec; 25(6):1849-57. PubMed ID: 15547726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High expression of Survivin, mapped to 17q25, is significantly associated with poor prognostic factors and promotes cell survival in human neuroblastoma.
    Islam A; Kageyama H; Takada N; Kawamoto T; Takayasu H; Isogai E; Ohira M; Hashizume K; Kobayashi H; Kaneko Y; Nakagawara A
    Oncogene; 2000 Feb; 19(5):617-23. PubMed ID: 10698506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2 expression in neuroblastoma is differentially regulated by differentiation inducers.
    Kim CJ; Kim HO; Choe YJ; Lee YA; Kim CW
    Anticancer Res; 1995; 15(5B):1997-2000. PubMed ID: 8572591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.